Immunogenicity and safety of hepatitis A vaccine in children with chronic liver disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 37, Issue 3, 2003, Pages 258-261

  Ferreira, Cristina Targa ^a,b   Da Silveira, Themis Reverbel ^a   Vieira, Sandra Maria ^a   Taniguchi, Adriano ^a   Pereira Lima, Jorge ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b NONE   (Brazil)

Author keywords

Chronic liver disease children; Cirrhosis; Geometric mean titers; Hepatitis A vaccine; Hepatitis A virus; Immunization

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; INACTIVATED VACCINE; LIVE VACCINE; VIRUS ANTIBODY;

ADOLESCENT; ARTICLE; CHILD; CHRONIC LIVER DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FEVER; HEADACHE; HEPATITIS; HEPATITIS A VIRUS; HUMAN; IMMUNOGENICITY; INJECTION PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPEN STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; BLOOD; CHRONIC DISEASE; HEPATITIS A; IMMUNOLOGY; INFANT; LIVER DISEASE; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

HEPATITIS A VIRUS;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VACCINES; HUMANS; INFANT; LIVER DISEASES; MALE; PROSPECTIVE STUDIES; TREATMENT OUTCOME; VACCINES, ATTENUATED;

EID: 1542786786     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200309000-00011     Document Type: Article

References (19)

1. Tapia-Conyer R, Santos JI, Cavalcanti AM, et al. Hepatitis A in Latin America: A changing epidemiologic pattern. Am J Trop Med Hyg 1999;61:825-29
2. Ciocca M, Ramonet M, Sasbón J, et al. Acute liver failure in children: Prospective study [abstract]. Hepatology 1998;28(suppl):1369.
3. Ackerman Z, Ablin J, Shouval D. Active immunization against hepatitis A is now warranted in glucose-6-phosphatedehydrogenase deficient subjects. Am J Gastroenterol 1996;91:413
4. Keeffe EB. Is Hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases? Am J Gastroenterol 1995;90:201-5.
5. Bell BP. Hepatitis A and hepatitis B vaccination of patients with chronic liver disease. Acta Gastroenterol Belg 2000;63:359-63
6. Keeffe EB, Iwarson S, McMahon BJ, et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998;27:881-6.
7. CDC. Recommended Childhood Immunization Schedule - United States. JAMA 2001;285:875-6.
8. CDC. Prevention of hepatitis A through active and passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1996;45(RR-15):1-31.
9. CDC. Prevention of hepatitis A through active and passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48(RR-12):1-37.
10. American Academy of Pediatrics, Committee on Infectious Diseases. Prevention of hepatitis A infection: Guidelines for use of hepatitis A vaccine and immune globulin. Pediatrics 1996;98:1207-15.
11. Schwarz KB, Balistreri W. Viral hepatitis. In: American Liver Foundation. Pediatric liver research Agenda 2000: A blueprint for the future research goals and strategies to treat prevent and conquer childhood liver diseases. New York: American Liver Foundation, 2000;56-63.
12. Pugh NH. Transection of the oesophagus for bleeding varizes. Br J Surg 1973;60:646-49.
13. Nebbia G, Giacchino R, Soncini R, et al. Hepatitis A vaccination in chronic carriers of hepatitis B virus. J Pediatr 1999;134:784-5.
14. Innis BL, Snitbhan R, Kunasol P, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994;271:1328-34.
15. Ginsberg GM, Slater PE, Shouval D. Cost-benefit analysis of a nationwide infant immunization programme against hepatitis A in an area of intermediate endemicity. J Hepatol 2001;34:92-9.
16. Cedema JB, Klizman D, Stapleton JT. Hepatitis A virus-specific humoral and cellular immune responses following immunization with a formalin-inactivated hepatitis A vaccine. Vaccine 2000;18:892-8
17. Dumot JA, Barnes DS, Younossi Z, et al. Immunogenicity of hepatitis A vaccine in decompensated liver disease. Am J Gastroenterol 1999;94:1601-4.
18. Stark K, Gunther M, Neuhaus R, et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 1999;180:2014-17.
19. McMahon BJ, Beller M, Williams J, et al. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 1996;150:733-9.